Skip to main content
. 2022 Nov 24;2022:6986445. doi: 10.1155/2022/6986445

Figure 2.

Figure 2

Anisomycin (AN) suppressed HCC cell migration through the p38 MAPK pathway. AN suppressed HCC cell migration (a) and healing ability (b). The effect was evaluated by transwell and wound-healing assay. SB203580 (SB) was used to rescue cells from AN treatment. N = 3; P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001. (c) The expression levels of epithelial-mesenchymal transition-related proteins in AN treatment (24 h).